Pillstats
Rx only · Injection · Intravenous

Esmolol Hydrochloride

Brands: Brevibloc · Esmolol Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)49737
US makers6 labelers
Packages14
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1002002993992025 Q12025 Q22025 Q32025 Q42026 Q1
175
Rx · 2026 Q1
3.3K
Units dispensed
-50%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Baxter Healthcare Corporationunknown8SUPPLYING
WG Critical Care, LLCunknown2SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Henry Schein Inc.unknown1SUPPLYING
Medical Purchasing Solutions, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 12, 2016
    RECALLRecall (Class II): Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL…

    Discoloration: presence of atypical yellow discoloration of the solution . — Recalling firm: Baxter Healthcare Corp. — Nationwide

  • Jun 16, 2014
    RECALLRecall (Class II): Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use I…

    Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating. — Recalling firm: Baxter Healthcare Corp. — Nationwide